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Abstract
Background: Interferon gamma (IFN-γ), an immunoregulatory cytokine, is known to control many microbial infections.
In a previous study, chicken interferon gamma (chIFN-γ) was found to be up-regulated following avian influenza virus
(AIV) infection in specific pathogen-free chickens. We aimed to investigate whether the pre-immune state induced by
chIFN-γ could generate an antiviral response against influenza virus.
Methods: We generated a chIFN-γ-expressing plasmid and transfected it into chicken embryo fibroblasts (CEFs) and
then infected the cells with human origin H1N1 or avian origin H9N2 influenza viruses. Viral titers of culture medium
were evaluated in MDCK cell and the viral RNA and IFN-stimulated genes (ISGs) were then quantified by real-time
reverse transcriptase polymerase. To further evaluate the role of the antiviral effect of chIFN-γ by using a backward
approach, synthetic small interfering RNAs (siRNA) targeting chIFN-γ were used to suppress chIFN-γ.
Results: The chIFN-γ-stimulated CEFs inhibited the replication of viral RNA (vRNA) and showed a mild decrease in the
infectious virus load released in the culture medium. Compared to the mock-transfected control, the messenger RNA
(mRNA) levels of type I IFNs and IFN-stimulated genes were up-regulated in the cells expressing chIFN-γ. After
treatment with the siRNA, we detected a higher expression of viral genes than that observed in the mock-transfected
control.
Conclusions: Our results suggest that apart from the important role played by chIFN-γ in the antiviral state generated
against influenza virus infection, the pre-immune state induced by chIFN-γ can be helpful in mitigating the
propagation of influenza virus.
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Pre-immune state
Background
Influenza A virus is an enveloped virus from the Ortho-
myxoviridae family, with an eight-segmented, single-
stranded, negative-sense RNA genome. It is classified
into subtypes based on the combination of 16 haem-
agglutinin (HA) and 9 neuraminidase proteins [1].
Because of its nature as an RNA virus, influenza virus is
able to modify its genome by any of the several types of
mutations, including antigenic variation, natural selec-
tion, and reassortment [2]. This has resulted in continu-
ing spread of avian influenza virus (AIV), and has
caused great economic loss in the poultry industry, des-
pite regular vaccination programs [3, 4]. The economic
losses inflicted by H9N2 low-pathogenic avian influenza
is, especially, an ongoing problem in domestic poultry
farms in South Korea since 1996 [5].
The members of the type I interferon (IFN) family
induce antiviral states by binding to a common receptor,
consisting of two interferon-α/β receptor subunits
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(IFNAR1 and IFNAR2), on the cell membrane of most
cells. JAK/STAT signaling via IFNAR1 and IFNAR2 en-
hances the expression of many antiviral proteins, includ-
ing myxovirus-resistance protein (Mx) GTPase, RNA-
dependent protein kinase (PKR), latent ribonuclease
(RNaseL), and oligo-adenylate synthetase (OAS). These
IFN-induced antiviral proteins play a critical role in in-
nate, as well as adaptive, immune responses against viral
infections [6]. Because of their non-specific and pattern-
recognition properties, these IFN-induced antiviral pro-
teins have an effect on various strains of the influenza
virus [7, 8]. IFN-γ, which is the only type II IFN, binds
to a distinct receptor comprising two IFN-γ receptor
subunits (IFNGR1 and IFNGR2). The binding of IFN-γ
to IFNGR induces the production of IFN regulatory fac-
tor (IRF)-9 (also known as ISGF3), via the JAK/STAT
signaling pathway. The involvement of common signal-
ing pathways means that IFN-γ can activate type I IFNs,
and may explain many overlapping effects of type I and
II IFNs [9].
Chicken IFN-γ (chIFN-γ), first cloned by Digby and
Lowenthal, is known as a regulator of immune re-
sponses, including antiviral defenses [10]. Several evi-
dence show that the chicken immune system following
infection with AIV begin to express proinflammatory cy-
tokines, which results in a general antiviral response
through the activation of a broad range of effector mole-
cules, including Mx, PKR, and OAS [11, 12]. We also
showed that immunocompromised chickens showed ele-
vated level of vRNA with relative down-regulation of
chIFN-γ after AIV infection [13]. This finding is evi-
dence to the fact that the regulation of proinflammatory
cytokines correlates with the antiviral status. In addition,
it has been shown to enhance the immune response of
vaccine against Marek's disease virus and Newcastle dis-
ease virus [14, 15]. The immunity-enhancing effects of
IFN-γ have also been reported in other avian species.
For example, administration of recombinant IFN-γ
inhibited the replication of duck hepatitis B hepatocytes
[16]. Although it’s not for viral infection, administration
of chIFN-γ to chicken enhanced weight gain in the face
of coccidial infection, which showed a possibility for
practical use of chIFN-γ [17].
On the basis of previous studies, we aimed to deter-
mine the antiviral effect of the pre-immune state
against H1N1 human and H9N2 avian influenza in-
fection in CEFs, which was investigated to evaluate
the influence of chIFN-γ expression on innate im-
munity. Although several studies showed a correlation
between AIV infection and type I IFNs, few studies
have investigated the antiviral effects of IFN-γ against
influenza infection at the cellular level [18]. In
addition, we compared the kinetics of antiviral gene
expression following influenza infection to evaluate
the effect of modulation of chIFN-γ on type I IFN
and IFN-induced antiviral genes.
Methods
Cells and virus
Madin-Darby canine kidney (MDCK) cells (ATCC, CRL-
34) were used to measure the viral titer of the CEF
medium. MDCK cells were maintained as a monolayer
culture in minimum essential medium (MEM) supple-
mented with 10 % fetal bovine serum (FBS) and 1 %
penicillin/streptomycin, at 37 °C with 5 % CO2. CEF cul-
tures were prepared from 10-day-old specific pathogen-
free (SPF) embryonated eggs, following established pro-
tocols [19]. CEFs were cultured in M199 (GIBCO, Grand
Island, N.Y.) and Ham's F-10 (Sigma, St Louis, MO,
USA) mixed medium, containing 10 % bovine serum
(BS), 0.65 % sodium bicarbonate, and 1 % penicillin/
streptomycin. H9N2 avian influenza virus (A/Korean na-
tive chicken/Korea/K040110/2010) and H1N1 human
influenza virus (A/NWS/1933) were propagated in 10-
day-old SPF embryonated eggs and kept frozen at −80 °
C for further use.
Plasmid construction
Chicken peripheral blood mononuclear cells (PBMCs)
were purified using Histopaque 1077 (Sigma) gradient
separation. The cells were grown overnight in 3 ml of
Roswell Park Memorial Institute (RPMI) medium sup-
plemented with 5 % FBS, 1 % penicillin/streptomycin,
and 10 μl of 2.5 mg/ml concanavalin A. Total RNA was
isolated from PBMCs by using an RNeasy mini kit (Qia-
gen, Hilden, Germany), and was used as a template for
cDNA synthesis using an Omniscript RT kit (Qiagen).
The chIFN-γ coding sequence was amplified using
primers designed to span the predicted chIFN-γ-coding
sequence, which was obtained from NCBI database
(GenBank accession no. AY501004.1). The amplified
PCR product was cloned into the pcDNA3.1(+) expres-
sion vector (Invitrogen, Darmstadt, Germany), amplified,
and purified using a Plasmid Maxi kit (Qiagen).
Transfection and detection of chIFN-γ
Briefly, 6 × 105 cells per well were seeded in 6-well cul-
ture plate and incubated at 37 °C for 24 h. The CEFs
(about 2 × 106 cells) were transfected with 0.5 μg of
pcDNA3.1(+) or pcDNA-chIFN-γ using Lipofectamine
2000 (Invitrogen), and the medium was harvested at 6,
12, 24, and 48 h post transfection. The medium samples
were then subjected to diafiltration, using 10-kDa mo-
lecular weight cut-off Vivaspin spin columns (Sartorius
Stedim Biotech, Goettingen, Germany), at 10,000 × g at
4 °C. The concentrated culture medium samples were
resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, and analyzed by western blotting using
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an anti-chIFN-γ rabbit polyclonal antibody (Kingfisher
Biotech, St Paul, MN, USA) and peroxidase-conjugated
anti-rabbit goat monoclonal secondary antibody (Sigma).
Immunofluorescence staining was also performed to
evaluate the expression of chIFN-γ. Transfected CEFs
were grown on 24-well plates for 1 day and fixed with
4 % paraformaldehyde in phosphate-buffered saline
(PBS) for 10 min at room temperature (20 to 25 °C).
The cells were permeabilized with 0.5 % Triton X-100 in
PBS for 7 min and washed three times with a washing
solution containing 10 % FBS and 0.2 % Tween-20 in
PBS. Then, the cells were incubated with anti-chIFN-γ
rabbit polyclonal antibody (Kingfisher Biotech) for 1 h at
room temperature. After washing, the secondary anti-
bodies conjugated with Alexa Fluor 488 goat anti-rabbit
immunoglobulin G (Invitrogen) were applied. After
staining with 4′,6-diamidino-2-phenylindole (Sigma), the
fluorescence images were acquired using an AxioVert
200 inverted-microscope (Carl Zeiss, Germany). The
percentage of fluorescent cells was calculated from fol-
lowing formula: % transfection efficacy = fluorescent cell
green fluorescent cell number / blue fluorescent cell
number × 100.
Virus infection of transfected CEFs
CEFs transfected with pcDNA3.1(+) or pcDNA-chIFN-γ
were prepared 24 h before infection. Transfected CEFs
were infected with H1N1 or H9N2 virus at a multi-
plicity of infection (MOI) of 0.01, which was diluted
in the CEF medium at 37 °C with gentle agitation
every 15 min. After 1 h of incubation, the unabsorbed
virus was removed, and the cells were washed with
PBS. Fresh medium supplemented with 1 μg/ml
tosylsulfonyl-phenylalanyl-chloromethyl ketone-treated
trypsin (Sigma) was added, and the plates were incu-
bated at 37 °C in with 5 % CO2. At 0, 6, 12, 24, and
48 h post infection (hpi), the supernatant and CEFs
were separated, harvested, and stored at −80 °C for
virus titration and vRNA quantification.
Virus titration
MDCK cells were used to determine the viral titer of
propagated influenza virus to verify the biological activ-
ity of the released infectious virion particles. The re-
leased virion particles accumulate in the culture medium
and can be quantified in the medium. A confluent 96-
well culture plate of MDCK cells was prepared at 24 h
before undertaking the virus titration (TCID50) assay.
The cells were washed once with PBS, and the medium
was replenished with serum-free MEM medium supple-
mented with 100 units/ml penicillin, 100 μg/ml strepto-
mycin, and 2 μg/ml trypsin. Serial dilutions of the
supernatant, from 1 log to 8 log, were performed, and
each dilution was added to eight wells of a 96-well
culture plate in triplicate. The plates were then observed
daily for cytopathic effects (CPE). The end-point of viral
dilution leading to CPE in 50 % of the inoculated wells
was estimated using the Karber method [20].
Quantification of vRNA and cytokine mRNA
For relative quantification of vRNA and cytokine mRNA
in CEFs, total RNA was extracted from virus-infected
CEFs samples by using RNeasy Mini Kit (Qiagen), ac-
cording to the manufacturer’s instructions. The vRNA
and IFN-stimulated genes (ISGs) were then quantified
by real-time reverse transcriptase polymerase chain reac-
tion (rRT-PCR) in a thermal cycler (Smart Cycler Sys-
tem, Cepheid, Sunnyvale, CA, USA) using One-Step
SYBR Green Master Mix II (Takara, Dalian, Jiangsu,
China) according to the manufacturer’s instructions. The
primer sets for hemagglutinin (HA), polymerase basic 2
(PB2) genes, chicken IFN-α, chicken IFN-β, chicken
myxovirus resistant 1 (chMx), chicken 2'-5' oligoadeny-
late synthetase (chOAS), chicken RNase L, and chicken
protein kinase R (chPKR) mRNAs are listed in Add-
itional file 1: Table S1. The vRNA was quantified and
compared to that in the mock-transfected control. The
expression of cytokines and ISGs was normalized using
the comparative 2-2ΔΔCt method, which was used to de-
termine the mean fold increase in the expression level of
the respective gene from the corresponding time point
in the uninfected cell [21].
Treatment with siRNA targeting chIFN-γ
SiRNA transfection, at a final concentration of 50 nM,
was carried out using Lipofectamine 2000 (Invitrogen) in
CEFs. An siRNA targeting chIFN-γ [chIFN-γ-siRNA
277 bp: 5'-CCGCACAUCAAACACAUAU(dTdT)-3'] and
a validated negative control siRNA [Negative control: 5'-
CCUACGCCAAUUUCGU-3'] were designed and synthe-
sized by ST Pharm Co., Ltd. Because we could not differ-
entiate mock-transfected CEF from the chIFN-γ-siRNA
transfected CEF using immunofluorescence assay, the
knockdown of chIFN-γ mRNA was confirmed by the real-
time RT-PCR. The primer set for chIFN- γ is listed in
Additional file 1: Table S1.
The CEFs were inoculated with H1N1 and H9N2 virus
at an MOI of 0.01 at 12 h after transfection. CEF culture
medium was harvested 48 hpi, and RNA was extracted
for rRT-PCR analysis. To compare viral gene replication
within CEFs, the vRNA was quantified by rRT-PCR as
described above.
Statistical analyses
Data are expressed as the mean and standard deviation.
Statistical differences for time related cytokine expres-
sion after transfection of pcDNA3.1(+) or pcDNA-
chIFN-γ were analyzed with two-way ANOVA using
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Prism 5 (GraphPad Co., San Diego, CA, USA). To com-
pare viral RNA difference between pcDNA3.1(+) and
pcDNA-chIFN-γ, unpaired student t-test was used. P
values < 0.05 were considered significant.
Results
Cloning and expression of chIFN-γ
Western blotting revealed the presence of 13–24-kDa
bands corresponding to chIFN-γ in the culture medium
of pcDNA-chIFN-γ-transfected CEFs. The bands de-
tected were of 3–4 different sizes, rather than a single
band of the calculated size (16.7 kDa), which corre-
sponded to its theoretical molecular weight. Major bands
were noted at 17 and 19 kDa, and weak bands were ob-
served above them. Although the samples were reduced
by 5 % 8-mercaptoethanol, we suppose that a dimeric
form of chIFN-γ was also observed at 48 h after trans-
fection in minor quantities which was not reduced. The
intensity of the bands increased, indicating higher levels
of expression, with time. No bands were detected in the
medium containing the mock-transfected control cells
(Fig. 1a). The expression of chIFN-γ in CEFs transfected
with pcDNA-chIFN-γ was also verified by an immuno-
fluorescence assay using an anti-chIFN-γ polyclonal
antibody (Fig. 1b), whereas the mock-transfected control
cells did not emit any fluorescence with the anti-chIFN-
γ polyclonal antibody. The percentage of fluorescent
cells was calculated from the image and transfection effi-
ciency of pcDNA-chIFN-γ was about 25%. These results
not only indicate that chIFN-γ was expressed success-
fully in CEFs but also that pcDNA3.1(+)-transfected
CEFs do not release detectable levels of chIFN-γ in the
culture medium or within the CEFs.
Inhibition of AIV replication in the CEF culture medium
To measure the amount of infectious viral particles that
were released into the culture supernatant, a TCID50 ti-
tration assay was performed by end-point dilution assay.
The CEFs transfected with pcDNA-chIFN-γ showed
lower levels of viral titer than did the cells transfected
with pcDNA3.1(+) after H1N1 and H9N2 virus infec-
tion. There were no differences in the titer during the
early phases of replication in both H1N1 and H9N2
virus infection. However, lower level of viral titer was
observed after 24 hpi with chIFN-γ. At 24 and 48 hpi,
the mean viral titer was significantly reduced by approxi-
mately 10 and 60 folds against H1N1 infection (Fig. 2a).
In H9N2 infection, no statistical reduction in virus titer
was observed at 6, 12, and 24 hpi. At 48 hpi, approxi-
mately 50-fold reduction in viral titer was observed in
H9N2 infection (Fig. 2b). These data demonstrate that
although the decrease was somewhat mild, the CEFs
stimulated by chIFN-γ ahead of infection reduce virus
replication in H1N1 and H9N2 infection.
Inhibition of AIV replication in CEF
Forty-eight hours after infection, the cells were har-
vested and analyzed by rRT-PCR. As compared to the
mock-transfected control, transfection with pcDNA-
chIFN-γ significantly reduced the fold change in viral
RNA levels after infection, from 2.2- to 17-fold (Fig. 3a).
These results suggest that both early (PB2) and late
(HA) transcribed genes were down-regulated in CEFs
Fig. 1 Expression of chIFN-γ in CEFs and the cell culture medium. a CEFs were transfected with pcDNA-IFN-γ. Then, the cell culture medium was
harvested at 6, 12, 24, and 48 h post transfection. The medium was centrifuged and concentrated using spin columns. Western blotting was
performed as described in Methods. b At 24 h post transfection, the localization of chIFN-γ in CEFs was demonstrated using anti-chIFN-γ
polyclonal rabbit antibody as the primary antibody and anti-rabbit IgG Alexa Fluor 488 goat antibody as the secondary antibody (green).
Cell nuclei were stained with 4,6-diamidino-2-phenylindole (blue)
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transfected with chIFN-γ. Although the reduction of
viral titer which were measured in culture medium was
approximately same in both viruses at 48 hpi, reduction
of viral gene within the CEFs was more potent against
H1N1 than H9N2 infection.
Effects of chIFN-γ-siRNA transfection on AIV replication in
CEFs
To investigate whether the down-regulation of chIFN-γ
resulted in the replication of H1N1 and H9N2 genes,
the siRNAs (chIFN-γ-siRNA 277 bp) were designed to
Fig. 2 Reduced viral titer of H1N1 and H9N2 influenza viruses in CEF expressing chIFN-γ. Twenty-four hours after transfection with pcDNA-IFN-γ, CEFs
were infected with H1N1 and H9N2 virus. Forty-eight hours post infection, MDCK cells were treated with a H1N1- and b H9N2-infected CEF culture
supernatants. TCID50 titer was measured by end-point dilution assay. Statistical significance was determined by one-way ANOVA (*P < 0.05, **P < 0.01,
and ***P < 0.001)
Fig. 3 Viral gene replication in CEF expressing chIFN-γ and suppressed by siRNA targeting chIFN-γ. CEFs were harvested and analyzed by real-
time RT-PCR after H1N1 and H9N2 virus infection. a The mRNAs of viral glycoprotein (HA) and viral polymerase (PB2) were significantly reduced in
pcDNA-chIFN-γ-transfected CEFs compared to the control. b HA and PB2 mRNA was significantly increased in siRNA targeting chIFN-γ transfected
CEFs compared to the control. Statistical significance was determined by unpaired student t-test (*P < 0.05, **P < 0.01, and ***P < 0.001)
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specifically target chIFN-γ mRNA. The expression levels
of chIFN-γ mRNA in the CEF culture medium were suc-
cessfully reduced by transfection with chIFN-γ-siRNA
277 bp [see Additional file 2]. When the cells were
transfected with the siRNA, the CEFs showed high levels
of HA and PB2 gene replication after infection; the levels
were significantly high, compared to the control (Fig. 3b).
This suggests that the suppression of chIFN-γ, which
was regulated before the infection, results in increased
replication of viral genes.
Regulation of ISGs by chIFN-γ
To study the regulation of ISGs after H1N1 and H9N2
virus infection, the expression level of each related gene,
including chIFN-α, chIFN-β, chMx, chPKR, chOAS, and
chRNaseL, was measured in triplicate by rRT-PCR. The
results for the cellular RNA samples were obtained at 0,
6, 12, 24, and 48 hpi. After H1N1 virus infection, the
pre-immune state induced by chIFN-γ showed signifi-
cantly increased expression of chIFN-α, chIFN-β, and
chRNaseL mRNA (Fig. 4a, 4b, and 4f). Unlike other
genes, chMx peaked early after H1N1 infection at 12 hpi
then declined, compared to that in the mock-transfected
control (Fig. 4c). However, there was no statistical differ-
ence in case of chPKR gene, which showed a similar ten-
dency in both chIFN-γ-transfected CEFs and mock-
transfected control cells (Fig. 4d). After H9N2 infection,
the pre-immune state induced by chIFN-γ stimulated
significantly increased gene expression of chIFN-α,
chIFN-β, chMx, and mRNA (Figs. 5a, 4b, and 4c).
ChIFN-α and chIFN-β genes exhibit an induction pat-
tern similar to that of H1N1 infection. The only differ-
ence was that early expression level (6 and 12 hpi) of
chIFN-β was slightly lower than that in H1N1 infection.
Compared to the mock-transfected control, chMx was
up-regulated with a significant increase, which was
maintained until 24 hpi (Fig. 5c). Unlike that observed
with H1N1 infection, chIFN-γ did not stimulate higher
expression of chOAS and chRNaseL. Likewise, expres-
sion of chPKR was not markedly high compared to that
observed in the mock-transfected control.
Discussion
The role of IFN-γ and antiviral proteins against influ-
enza virus is highlighted by the studies; 1) Pretreated hu-
man IFN-γ inhibit virus replication in St. Jude porcine
lung epithelial cell, 2) Influenza virus encodes a non-
structural protein 1(NS1) designed to resist antiviral
properties of PKR and OAS/RNase L [22, 23]. In a previ-
ous study, we had demonstrated that immunocomprom-
ised chickens with decreased chIFN-γ mRNA expression
in blood show relatively higher mortality than normal
chickens after H9N2 infection [13]. Taken together, we
supposed that upregulation of chIFN-γ could be one of
the key factors that need to be disrupted for successful
infection of influenza virus. Therefore, we hypothesized
that the pre-immune state induced by IFNs would de-
crease influenza virus infection, which could prevent the
host from failure to induce a cell-mediated antiviral re-
sponse. Although few studies tried to understand the
pre-treatment effects of IFNs, none of them focused on
chIFN-γ-induced antiviral response against AIV infec-
tion in CEFs.
CEFs are a useful tool for studying the interactions be-
tween avian viruses and immune-related genes. Because
viral infection of cell culture systems can be controlled,
specific molecular and cellular changes that occur in the
host cells early during the course of the infection can be
analyzed. Therefore, the response of cell culture systems
to influenza has been characterized in many ways [24–
26]. Compared to other expression systems, the chIFN-γ
produced by CEFs showed a different molecular size
varying from 13 to 24 kDa [27, 28]. Two major bands
were observed, one of which corresponds to the theoret-
ically calculated size of chIFN-γ, while the other one was
higher than the expected size. C-terminus truncation
might have occurred, as observed when chIFN-γ was
expressed in Escherichia coli [29]. The bands located
above the major bands could be produced by glycosyla-
tion, three possible sites for which are present on
chIFN-γ. When we observe the immunofluorescence im-
aging, the overall transfection efficiency of the chIFN-γ
was about 25 %. Because cell growth inhibition and
apoptosis are one of the effects of IFN-γ, we controlled
the transfection efficiency under the 30 %, which did not
affect the cell health [30].
Immediate early induction of some ISGs in the CEFs
after H1N1 and H9N2 virus infection is well character-
ized by Sutejo et al. [24]. To the best of our knowledge,
however, no previous studies have studied how the
chIFN-γ-induced pre-immune state affects antiviral gene
expression after influenza infection in CEFs. In our
study, pretreatment of chIFN-γ lead to elevation of
chIFN-α and chIFN-β mRNA levels. This is consistent
with previous studies [30], indicating that the induction
of IFN-γ leads to cross-talk between the IFN-α and IFN-
β pathways. However, the approach used here differs in
terms of the chIFN-γ expression system of CEFs, not in
the addition of recombinant chIFN-γ to the cell culture
medium. In addition, we observed the regulation of
ISGs, which is related to the antiviral effect against influ-
enza infection. We also found that because fibroblasts
are a major cellular source of IFN-β, the fold increase in
chIFN-β was higher than that in chIFN-α in both H1N1
and H9N2. [31]
ChMx expression markedly surged early after the in-
fection, supporting previous findings [32]. However, it
was previously reported that transfected cells expressing
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chMx do not lead to enhanced resistance to influenza
virus [33]. An additional study was performed to under-
stand the polymorphisms of the chMx protein that lead
to alterations in antiviral activity [34]. Notably, the eleva-
tion of chMx mRNA was faster than that of other ISGs.
These data suggest that the pre-immune state induced
Fig. 4 Relative expression of type I interferons and interferon-stimulated genes following H1N1 infection in CEFs. Twenty-four hours after transfection
with pcDNA-IFN-γ, CEFs were infected with 0.01 MOI of H1N1 virus. At 0, 6, 12, 24, and 48 hpi, the total RNA content of CEFs was extracted and
analyzed by real-time RT-PCR, as described in Methods. The expression levels of chIFN-α (a), chIFN-β (b), chMx (c), chPKR (d), and chOAS (e), and
chRNaseL (f) were assessed. Statistical significance was determined by two-way ANOVA (*P < 0.05, **P < 0.01, and ***P < 0.001)
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by chIFN-γ in CEFs led to rapid induction of chMx. This
may play a key role in the observation that H1N1 and
H9N2 virus infected into chIFN-γ-transfected CEFs had
an approximately 17 and 2.2-fold reduced HA gene rep-
lication rate compared to the virus infected into the
mock-transfected control cells. The finding that the peak
Fig. 5 Relative expression of type I interferons and interferon-stimulated genes following H9N2 infection in CEFs. Twenty-four hours after transfection
with pcDNA-IFN-γ, CEFs were infected with 0.01 MOI of H9N2 virus. At 0, 6, 12, 24, and 48 hpi, the total RNA content of CEFs was extracted and
analyzed by real-time RT-PCR, as described in Methods. The expression levels of chIFN-α (a), chIFN-β (b), chMx (c), chPKR (d), and chOAS (e), and
chRNaseL (f) were assessed. Statistical significance was determined by two-way ANOVA (*P < 0.05, **P < 0.01, and ***P < 0.001)
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time of expression was shorter in H1N1 infection than
in H9N2 infection was unexpected. Unfortunately, we
cannot directly compare our findings with those of pre-
vious studies because we used different viral strains and
cells. However, there is evidence that suggests that infec-
tion with H9N2 of avian origin induces more Mx gene
than does H1N1 of human origin [24]. It should be fur-
ther confirmed that this observation reflects the specific
property of each virus, to further understand the se-
quence of events during the early phase of infection.
As reported previously [35], the IFN-induced antiviral
proteins chOAS/RNaseL and chPKR are up-regulated as
part of the host protective response in chickens infected
with the AIV subtype H9N2. In this study, although the
expression of chPKR was not significantly up-regulated
in the CEFs transfected with pcDNA-chIFN-γ, the in-
crease in the levels of chOAS and chRNaseL suggests
that the antiviral status was induced by the pre-immune
state after H1N1 infection, but not after H9N2 infection.
Usually, PKR and OAS are activated upon detection of
double-stranded vRNA, leading to arrest of translation
and inhibition of viral protein synthesis [36]. The pre-
immune state stimulated by chIFN-γ did not induce in-
creased expression of chPKR and chOAS, compared to
the mock-transfected control cells. Although the in-
crease of chOAS was higher in H1N1 infection than in
H9N2 infection, because it was observed at 48 hpi, it
cannot support the marked increase of chRNaseL after
H1N1 infection. Although the viral dsRNA involved in
activating chOAS acted similarly in H1N1 and H9N2
virus infections, the H9N2 virus derived from avian spe-
cies could be more efficient in sequestering viral dsRNA
from chOAS by NS protein in the CEFs [37].
To investigate the effects of chIFN-γ-induced pre-
immune state, the released H1N1 and H9N2 viral parti-
cles were measured in the CEF culture medium with and
without chIFN-γ activity. Although the decrease in virus
replication was minor, the chIFN-γ-producing CEFs can
reduce virus replication in H1N1 and H9N2 infection.
Our backward approach involved the thought that the
suppression of chIFN-γ with siRNA increases virus gene
replication in H1N1 and H9N2 infection in the CEFs.
This reduction in chIFN-γ levels was accompanied by an
increase in the expression of viral HA and PB2 genes in
chIFN-γ-siRNA 277 bp-transfected CEFs.
Conclusions
In this study, an expression system was used to stimulate
the intrinsic cellular defense mechanism in CEFs by
using cloned chIFN-γ. Overall, our data showed that the
pre-immune state induced by chIFN-γ in CEFs success-
fully develops intrinsic immunity by enhancing the ex-
pression of ISGs such as chMx, chOAS, and chRNaseL.
Importantly, these ISGs have been reported to exert
antiviral activities against influenza infection. These re-
sults suggest that stimulating innate immunity before
the infection prevents virus replication and inhibits the
release of viral progeny. We believe that our results can
contribute to improved understanding of the mechanism
underlying the preventive effect exerted by chIFN-γ
against influenza.
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